Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
-
Published:2019-01
Issue:
Volume:Volume 11
Page:99-110
-
ISSN:1178-6981
-
Container-title:ClinicoEconomics and Outcomes Research
-
language:en
-
Short-container-title:CEOR
Author:
Ellis Lorie A.ORCID,
Malangone-Monaco Elisabetta,
Varker Helen,
Stetsovsky Diana,
Kubacki MaureenORCID,
DeHoratius Raphael J,
Kafka Shelly
Publisher
Informa UK Limited
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)